Stocks
Revelation Biosciences, Inc.REVB
NASDAQHealthcareBiotechnology$1.26+2.06%
A clinical-stage biotechnology company developing immunologic therapies designed to modulate the body’s innate immune response, with programs targeting viral infections and other inflammatory conditions. Its pipeline includes intranasal and systemic candidates intended to stimulate protective immune...
Market Cap: $1.9M52W Range: $1.19 – $44.77
Congressional Interest in Revelation Biosciences, Inc. (REVB)
1 member of Congress has disclosed 13 trades in Revelation Biosciences, Inc. (REVB), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 13 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
1
Buys
0
Sells
13
Who in Congress Is Trading REVB?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-07-31 | Patrick J Toomey | sell | $15K – $50K |
| 2018-07-27 | Patrick J Toomey | sell | $15K – $50K |